- Home
- UVV vs BCRX Comparison
UVV vs BCRX Comparison
Compare UVV & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UVV
- BCRX
- Stock Information
- Founded
- UVV 1886
- BCRX 1986
- Country
- UVV United States
- BCRX United States
- Employees
- UVV N/A
- BCRX N/A
- Industry
- UVV Farming/Seeds/Milling
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UVV Industrials
- BCRX Health Care
- Exchange
- UVV Nasdaq
- BCRX Nasdaq
- Market Cap
- UVV 1.3B
- BCRX 1.4B
- IPO Year
- UVV N/A
- BCRX 1994
- Fundamental
- Price
- UVV $51.21
- BCRX $6.76
- Analyst Decision
- UVV
- BCRX Strong Buy
- Analyst Count
- UVV 0
- BCRX 11
- Target Price
- UVV N/A
- BCRX $19.55
- AVG Volume (30 Days)
- UVV 180.2K
- BCRX 7.3M
- Earning Date
- UVV 08-06-2025
- BCRX 11-03-2025
- Dividend Yield
- UVV 6.46%
- BCRX N/A
- EPS Growth
- UVV N/A
- BCRX N/A
- EPS
- UVV 4.11
- BCRX N/A
- Revenue
- UVV $2,943,996,000.00
- BCRX $599,816,000.00
- Revenue This Year
- UVV $1.52
- BCRX $41.57
- Revenue Next Year
- UVV $0.97
- BCRX $6.25
- P/E Ratio
- UVV $12.36
- BCRX N/A
- Revenue Growth
- UVV 4.11
- BCRX 45.38
- 52 Week Low
- UVV $49.40
- BCRX $6.00
- 52 Week High
- UVV $67.33
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- UVV 35.95
- BCRX 39.74
- Support Level
- UVV $52.26
- BCRX $6.44
- Resistance Level
- UVV $51.44
- BCRX $7.47
- Average True Range (ATR)
- UVV 0.92
- BCRX 0.26
- MACD
- UVV -0.18
- BCRX 0.03
- Stochastic Oscillator
- UVV 28.10
- BCRX 39.32
About UVV Universal Corporation
Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.